Cited by 239Fungal Infections and StudiesAntifungal resistance and susceptibilityBacterial Infections and Vaccines

Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans

Open access
Rittershaus, P. C.·2006·Journal of Clinical Investigation

Abstract

The pathogenic fungus Cryptococcus neoformans infects humans upon inhalation and causes the most common fungal meningoencephalitis in immunocompromised subjects worldwide. In the host, C. neoformans is found both intracellularly and extracellularly, but how these two components contribute to the development of the disease is largely unknown. Here we show that the glycosphingolipid glucosylceramide (GlcCer), which is present in C. neoformans, was essential for fungal growth in host extracellular environments, such as in alveolar spaces and in the bloodstream, which are characterized by a neutral/alkaline pH, but not in the host intracellular environment, such as in the phagolysosome of macrophages, which is characteristically acidic. Indeed, a C. neoformans mutant strain lacking GlcCer did not grow in vitro at a neutral/alkaline pH, yet it had no growth defect at an acidic pH. The mechanism by which GlcCer regulates alkali tolerance was by allowing the transition of C. neoformans through the cell cycle. This study establishes C. neoformans GlcCer as a key virulence factor of cryptococcal pathogenicity, with important implications for future development of new antifungal strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci27890

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • APX001, alone or in combination with fluconazole, significantly decreased the fungal burden in both the lungs and the brain in a mouse model of cryptococcal infection.

    “APX001, alone or in combination with fluconazole, significantly decreased the fungal burden in both the lungs and the brain in a mouse model of cryptococcal infection98.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 47 · Cited by 239

Research works printed but not linked: 1

  1. Villee, C.A. 1957. Biology. Saunders. Philadelphia, Pennsylvania, USA. 615 pp.

Authors
Rittershaus, P. C.
Affiliations
Medical University of South Carolina (US)
Corresponding author
Rittershaus, P. C.
Venue
Journal of Clinical Investigation
Published
2006-06-01
Volume
116
Issue
6
Pages
1651-1659
ISSN
0021-9738 (ISSN-L)
OpenAlex
W1966404042
Cited by
239
References
47
Citations by year
2026: 8 · 2025: 10 · 2024: 9 · 2023: 9 · 2022: 8 · 2021: 20 · 2020: 21 · 2019: 10 · 2018: 11 · 2017: 7 · 2016: 18 · 2015: 17 · 2014: 11 · 2013: 7 · 2012: 7
FWCI
9.27
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • SMARTech Repository (Georgia Institute of Technology) (submittedVersion)
Funders
  • National Science Foundation (0132573)
  • National Institutes of Health (1c06rr015455-01a1, GM-069338)
  • National Institute of General Medical Sciences (U54GM069338, GM 069338)
  • National Institute of Allergy and Infectious Diseases (AI56168, R01AI056168)
  • National Center for Research Resources (P20RR017677, RR 17677, C06 RR-015455)
  • Office of Experimental Program to Stimulate Competitive Research (EPS-0132573)
Topics
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords
Cryptococcus neoformans, glucosylceramide, glucosylceramide synthase, fungal pathogenicity, virulence factors, glycosphingolipids, alkaline tolerance, cell cycle, phagolysosomes, macrophages, bloodstream infection, antifungal drug targets
MeSH terms
Animals, Cell Cycle, Cryptococcus neoformans, Fungal Proteins, Glucosyltransferases, Humans, Hydrogen-Ion Concentration, Lung, Mice, Inbred CBA, Survival Rate, Virulence Factors, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review